- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Menu
Ankylosing spondylitis is an inflammatory disease that, over time, can cause some of the small bones in your spine (vertebrae) to fuse together. This fusion makes the spine less flexible and can lead to a forward bent posture. When ribs are affected, it can be difficult to breathe deeply. Ankylosing spondylitis affects men more often than women. Signs and symptoms typically begin in early adulthood. The inflammation can also occur in other parts of your body – most commonly in the eyes.
Showing 1–12 of 28 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
100 mg/mL |
– |
2 mg |
-80°C |
2023.10 |
354,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
100 mg/mL |
– |
4 mg |
-80°C |
2024.02 |
354,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2025.05 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2018.09 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2018.12 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2019.03 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2019.03 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2019.07 |
451,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Idacio® |
50 mg/mL |
– |
2 mg |
-80°C |
2023.10 |
355,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hyrimoz® |
50 mg/mL |
– |
2 mg |
-80°C |
2024.06 |
304,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Erelzi® |
50 mg/mL |
– |
4 mg |
-80°C |
2023.04 |
272,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Nepexto® |
50 mg/mL |
– |
4 mg |
-80 °C |
2023.08 |
272,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Remsima® |
10 mg/mL |
– |
3 mg |
tba |
tba |
233,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.11 |
204,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2019.08 |
204,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2020.02 |
204,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2021.03 |
204,00 € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
2020.12 |
204,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Flixabi® |
10 mg/mL |
– |
2 mg |
-80°C |
2025.01 |
239,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Inflectra® |
10 mg/mL |
– |
2 mg |
- 80°C |
2027.03 |
240,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
yes |
6 mg |
-80°C |
2022.11 |
345,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
2017.12 |
345,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
2019.02 |
345,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6mg |
-80°C |
2022.12 |
345,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
2018.03 |
345,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
2019.09 |
345,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
2018.06 |
345,00 € |
||
IL-17A |
Monoclonal Antibody |
Cosentyx® |
150 mg/mL |
– |
6 mg |
-80°C |
2018.12 |
345,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany
